|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 19.54 USD | +1.03% |
|
+0.31% | -35.87% |
| 08-12 | BofA Securities Adjusts Price Target on Beta Bionics to $18 From $15.50 | MT |
| 08-11 | BofA Securities Adjusts Beta Bionics Price Target to $18 From $15.50 | MT |
Company Valuation: Beta Bionics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 1,341 | 879.1 | - | - |
| Change | - | -34.47% | - | - |
| Enterprise Value (EV) 1 | 1,130 | 745.4 | 805.8 | 829 |
| Change | - | -34.01% | 8.1% | 2.89% |
| P/E | -16.8x | -9.15x | -9.09x | -11.7x |
| PBR | 4.7x | 3.91x | 5.1x | 5.53x |
| PEG | 0.2x | -0.5x | -13.36x | 0.5x |
| Capitalization / Revenue | 13.4x | 6.57x | 4.89x | 3.52x |
| EV / Revenue | 11.3x | 5.57x | 4.49x | 3.32x |
| EV / EBITDA | -21.4x | -10.3x | -11.9x | -19.9x |
| EV / EBIT | -15.8x | -7.19x | -7.81x | -9.64x |
| EV / FCF | -20.1x | -8.39x | -9.02x | -11.1x |
| FCF Yield | -4.98% | -11.9% | -11.1% | -8.99% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -1.81 | -2.135 | -2.15 | -1.665 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 100.3 | 133.9 | 179.7 | 249.6 |
| EBITDA 1 | -52.75 | -72.67 | -67.65 | -41.64 |
| EBIT 1 | -71.68 | -103.7 | -103.1 | -86 |
| Net income 1 | -73.2 | -94.91 | -96.44 | -78.34 |
| Net Debt 1 | -211.9 | -133.7 | -73.32 | -50.07 |
| Reference price 2 | 30.47 | 19.54 | 19.54 | 19.54 |
| Nbr of stocks (in thousands) | 44,025 | 44,990 | - | - |
| Announcement Date | 2/17/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.06x | 5.5x | -10.13x | -.--% | 870M | |
| 31.56x | 5.56x | 21.3x | 0.29% | 234B | |
| 36.33x | 6.52x | 20.68x | 0.66% | 151B | |
| 40.63x | 10.56x | 23.34x | -.--% | 131B | |
| 17.98x | 3.68x | 11.93x | -.--% | 69.81B | |
| 35.87x | 7.2x | 22.79x | -.--% | 52.33B | |
| 19.45x | 2.34x | 11.69x | 2.62% | 50.91B | |
| 30.16x | 6.01x | 20.62x | 0.66% | 43.8B | |
| 72.51x | 6.91x | 21.05x | -.--% | 40.69B | |
| 20.46x | 5.68x | 14.67x | 1.13% | 34B | |
| Average | 29.59x | 6.00x | 15.79x | 0.54% | 80.9B | |
| Weighted average by Cap. | 33.74x | 6.39x | 19.83x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BBNX Stock
- Valuation Beta Bionics, Inc.
Select your edition
All financial news and data tailored to specific country editions
